Food and Drug Administration

Vaccines and Related Biological Products Advisory Committee

February 19, 2004

Slides

Options for Influenza Virus Vaccine Composition 2004-2005, Dr. Roland Levandowski, MD (HTM) (PPT)

Preparation of Reference Influenza Viruses in Mammalian Cells: FDA Perspective, Dr. Zhiping Ye, MD, PhD (HTM) (PPT)